DMAC (DiaMedica Therapeutics) Cyclically Adjusted Book per Share: $1.07 (As of Mar. 2026)


DMAC DiaMedica Therapeutics Inc DMAC
31 GF Score
Price $6.36
! 1 Warning Sign
View Full Analysis

What is DiaMedica Therapeutics Cyclically Adjusted Book per Share?

DiaMedica Therapeutics DMAC +1.75% 31 Cyclically Adjusted Book per Share is $1.07 as of Mar. 2026. GuruFocus rates DMAC with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

DiaMedica Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was $0.877. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, DiaMedica Therapeutics's average Cyclically Adjusted Book Growth Rate was 17.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of DiaMedica Therapeutics was 17.40% per year. The lowest was -19.50% per year. And the median was -16.40% per year.

As of today (2026-06-25), DiaMedica Therapeutics's current stock price is $6.36. DiaMedica Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $1.07. DiaMedica Therapeutics's Cyclically Adjusted PB Ratio of today is 5.94.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of DiaMedica Therapeutics was 9.31. The lowest was 1.01. And the median was 3.36.


DiaMedica Therapeutics  (NAS:DMAC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

DiaMedica Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.36/1.07
=5.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of DiaMedica Therapeutics was 9.31. The lowest was 1.01. And the median was 3.36.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


DiaMedica Therapeutics Cyclically Adjusted Book per Share Related Terms


DiaMedica Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for DiaMedica Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DiaMedica Therapeutics Cyclically Adjusted Book per Share Chart

DiaMedica Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 0.63 0.70 0.86 1.02

DiaMedica Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.94 0.98 1.02 1.07

DMAC vs BCYC, RZLT, ABEO: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, DiaMedica Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DiaMedica Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DiaMedica Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DiaMedica Therapeutics's Cyclically Adjusted PB Ratio falls into.


DMAC
31GF Score
DiaMedica Therapeutics Inc DMAC
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DiaMedica Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DiaMedica Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.877/330.2130*330.2130
=0.877

Current CPI (Mar. 2026) = 330.2130.

DiaMedica Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.230 241.018 -0.315
201609 0.293 241.428 0.401
201612 0.201 241.432 0.275
201703 0.001 243.801 0.001
201706 0.121 244.955 0.163
201709 -0.005 246.819 -0.007
201712 0.125 246.524 0.167
201803 0.606 249.554 0.802
201806 0.187 251.989 0.245
201809 0.171 252.439 0.224
201812 1.424 251.233 1.872
201903 1.163 254.202 1.511
201906 0.975 256.143 1.257
201909 0.808 256.759 1.039
201912 0.634 256.974 0.815
202003 0.942 258.115 1.205
202006 0.797 257.797 1.021
202009 1.588 260.280 2.015
202012 1.388 260.474 1.760
202103 1.232 264.877 1.536
202106 1.082 271.696 1.315
202109 1.779 274.310 2.142
202112 1.665 278.802 1.972
202203 1.542 287.504 1.771
202206 1.426 296.311 1.589
202209 1.327 296.808 1.476
202212 1.204 296.797 1.340
202303 1.021 301.836 1.117
202306 1.574 305.109 1.704
202309 1.466 307.789 1.573
202312 1.345 306.746 1.448
202403 1.221 312.332 1.291
202406 1.251 314.175 1.315
202409 1.122 315.301 1.175
202412 0.951 315.605 0.995
202503 0.792 319.799 0.818
202506 0.631 322.561 0.646
202509 0.991 324.800 1.008
202512 1.044 324.054 1.064
202603 0.877 330.213 0.877

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $1.07 mean?
DiaMedica Therapeutics (DMAC) has a Cyclically Adjusted Book per Share of $1.07 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on DiaMedica Therapeutics and its competitors.
Is DiaMedica Therapeutics' Cyclically Adjusted Book per Share too high?
DiaMedica Therapeutics' current Cyclically Adjusted Book per Share is $1.07. Overall, DiaMedica Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does DiaMedica Therapeutics' Cyclically Adjusted Book per Share compare to BCYC and RZLT?
DiaMedica Therapeutics' Cyclically Adjusted Book per Share of $1.07 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on DiaMedica Therapeutics and its competitors. DiaMedica Therapeutics's current Cyclically Adjusted Book per Share is $1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DiaMedica Therapeutics stock overvalued right now?
DiaMedica Therapeutics (DMAC) has a current Cyclically Adjusted Book per Share of $1.07. The current Cyclically Adjusted Book per Share is $1.07. DiaMedica Therapeutics' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For DiaMedica Therapeutics (DMAC), the current Cyclically Adjusted Book per Share is $1.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DiaMedica Therapeutics Business Description

Address 301 Carlson Parkway, Suite 210, Minneapolis, MN, USA, 55305
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.
31GF Score

Get the complete analysis for DMAC

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.36
Price